BBB National Programs Decision Summaries
BBB National Programs provides summaries of all case decisions from the National Advertising Division (NAD), National Advertising Review Board (NARB), Children’s Advertising Review Unit (CARU), Direct Selling Self-Regulatory Council (DSSRC), and Digital Advertising Accountability Program (DAAP). Subscribe to receive a weekly wrap-up of published case decisions in your inbox.
- All
-
9/17/2012 - NARB Recommends Colgate Discontinue Certain Advertising Claims for ‘Sensitive Pro-Relief’ Toothpaste
A National Advertising Review Board (NARB) panel has recommended that Colgate-Palmolive Company discontinue certain advertising claims for Sensitive Pro-Relief toothpaste, including claims of “faster” relief. -
9/17/2012 - NARB Recommends Fair Trade USA Modify Composite-Products Seal to Better Inform Consumers of ‘Fair-Trade’ Sourced Content
A National Advertising Review Board (NARB) panel has recommended that Fair Trade USA – formerly TransFair – require users of the organization’s “Fair Trade Certified” seal for composite products to provide additional information to consumers. -
2/09/2012 - NARB recommends Staples modify, discontinue “free” claims
A National Advertising Review Board (NARB) panel has recommended that Staples discontinue or modify the advertising claim “[I]it’s like getting supplies for FREE.” -
1/24/2012 - NARB PANEL RECOMMENDS NOVARTIS DISCONTINUE CLAIMS THAT EXCEDRIN STARTS RELIEVING HEADACHE PAIN FASTER THAN ADVIL Claims at Issue Challenged by Pfizer Consumer Healthcare
A National Advertising Review Board (NARB) panel has recommended that Novartis Consumer Health, Inc., discontinue advertising claims that the company’s Excedrin Extra Strength product starts relieving headache pain faster than Advil. The claims at issue were initially challenged before the National Advertising Division (NAD) of the Council of Better Business Bureaus by Pfizer Consumer Healthcare, the maker ofAdvil.